IHT Wealth Management’s CervoMed CRVO Stock Holding History

IHT Wealth Management’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3	Closed	-$2K	–	608
2018 Q1	$2K	Hold	3	–	–	﹤0.01%	1488
2017 Q4	$5K	Buy	+3	New	+$4.86K	﹤0.01%	1325

Other funds holding CRVO

SRCM

Swift Run Capital Management Charlottesville, Virginia $51.8M AUM 6.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WTC

WhitTier Trust Company Reno, Nevada $4.87B AUM 25.35% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

SFM

Signature Financial Management Norfolk, Virginia $416M AUM 8.59% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

IHT Wealth Management's CRVO Position: Q2 2018 in Review

IHT Wealth Management sold out of CervoMed (CRVO) in Q2 2018, closing a stake of 3 shares — an estimated $2K sold.

IHT Wealth Management first reported a position in CRVO in Q4 2017 and held it in 2 quarters. The position peaked at $5K in Q4 2017. 14 funds tracked by Wall St. Rank hold CRVO as of Q2 2018.

IHT Wealth Management reported no remaining CervoMed position as of Q2 2018 after selling out during the quarter.
IHT Wealth Management sold 3 CervoMed shares in Q2 2018, an estimated $2K.
IHT Wealth Management first reported a position in CervoMed in Q4 2017 and held it in 2 quarters.
IHT Wealth Management's CervoMed position peaked at $5K in Q4 2017.
14 funds tracked by Wall St. Rank held CervoMed as of Q2 2018.

Based on IHT Wealth Management's 13F filing for Q2 2018, filed 13 Aug 2018.